Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q1 2026 Earnings Call Transcript
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q1 2026 Earnings Call Transcript May 12, 2026Acumen Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.33, expectations were $-0.40278.


